Latest news

Insights

Top 10 Data Architecture Challenges in Modern Pharma Organizations

Executive Summary Data has become one of the most valuable strategic assets in the pharmaceutical industry. Every stage of the...
Insights

The Next Evolution of Decentralized Clinical Trials

Executive Summary Decentralized clinical trials (DCTs) emerged as one of the most significant innovations in clinical research over the past...
Regulatory

Despite a mid-stage miss, Mirum and Incyte strengthen the case for approval in uncommon bone disease

Incyte and Mirum Pharmaceuticals are taking a step closer to approval of their investigational pill for fibrodysplasia ossificans progressiva...
Clinical

Phase 3 Lagoon Trial Misses Survival Goal for Jazz’s Zepzelca in Second-Line Small Cell Lung Cancer

Jazz Pharmaceuticals said its phase 3 Lagoon trial evaluating Zepzelca as a second-line treatment for metastatic small-cell lung cancer...
Insights

Is Pharma Ready for the Age of Autonomous Work?

Executive Summary For years, pharmaceutical organizations have focused on automating...
Manufacturing

Following Navacaprant’s disappointing late-stage results, Neumora will fire thirty-five percent of its employees

Neumora announced that its two studies evaluating navacaprant in...
Regulatory

FDA Approves Welireg-Keytruda Combination for Adjuvant Treatment of Clear Cell Renal Cell Carcinoma

Merck & Co. has received U.S. FDA approval for a combination of Welireg and Keytruda as an adjuvant treatment...
Clinical

Caribou Gets CAR-T Boost Ahead of Phase 3 Trial

Caribou Biosciences has reported that its CAR-T cell therapy candidate achieved a median progression-free survival (PFS) of 17.1 months,...
Clinical

Takeda’s Inhibitor Gets the Better of BMS’ Sotyktu in Phase 3 Psoriasis Battle

Takeda has outperformed Bristol Myers Squibb (BMS) in the competition among TYK2 inhibitors, edging out Sotyktu and strengthening its...
Insights

Top 10 Forces Reshaping the Future of Life Sciences Operations

Executive Summary Life sciences operations are undergoing one of the...
Insights

Precision Medicine Moves From Vision to Reality

Executive Summary For decades, precision medicine was viewed as one...
Insights

Digital Pharma Manufacturing Is Finally Delivering on Its Promise

Executive Summary For more than two decades, pharmaceutical manufacturers have invested heavily in digital transformation initiatives. The vision was compelling. Connected production...
Insights

How Commercial Teams Are Using AI to Improve Launch Performance

Executive Summary Product launches have always been among the most critical moments in the pharmaceutical industry. A successful launch can establish...
Clinical

Sanofi Ends Phase 3 Trial of Riliprubart in CIDP After Interim Review

Sanofi has discontinued one of its phase 3 clinical trials evaluating riliprubart for chronic inflammatory demyelinating polyneuropathy (CIDP) after...
Commercial

Sionna Pens Deal With AbbVie For Cystic Fibrosis Drugs

Sionna Therapeutics has swiftly found a way to put...
Commercial

Sutro and Astellas enter partnership for development of immunostimulatory ADCs

Sutro Biopharm and Astellas Pharma have entered a strategic,...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

Regulatory

Insights

The Next Evolution of Decentralized Clinical Trials

Executive Summary Decentralized clinical trials (DCTs) emerged as one of...
Regulatory

Despite a mid-stage miss, Mirum and Incyte strengthen the case for approval in uncommon bone disease

Incyte and Mirum Pharmaceuticals are taking a step closer...
Clinical

Phase 3 Lagoon Trial Misses Survival Goal for Jazz’s Zepzelca in Second-Line Small Cell Lung Cancer

Jazz Pharmaceuticals said its phase 3 Lagoon trial evaluating...
Clinical

Novartis Reports Positive Phase 1/2 Results for Del-Brax in FSHD

Novartis has reported positive topline results from the Phase...

Research & Development

Market Access

Manufacturing

Novartis Names Texas as Site For RadioPharma Production Facility

Novartis is moving quickly to outline how radiopharmaceutical manufacturing...
Manufacturing

Cellares Raises $257 Million Series D to Expand Global Cell Therapy Manufacturing

Cellares has raised $257 million in a Series D...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Data Architecture Challenges in Modern Pharma Organizations

Executive Summary Data has become one of the most valuable...
Editorial Team -